CHAMPIONS ONCOLOGY, INC. (CSBR) Free cash flow 2017–2026
CHAMPIONS ONCOLOGY, INC. (CSBR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$5.0MFY2026 · since FY2017: -$3.6M → -$5.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$5.0M | -172.0% |
| FY2025 | $7.0M | +200.3% |
| FY2024 | -$7.0M | -733.9% |
| FY2023 | $1.1M | -73.3% |
| FY2022 | $4.1M | +182.9% |
| FY2021 | -$5.0M | -824.4% |
| FY2020 | $685,000 | -33.4% |
| FY2019 | $1.0M | +141.9% |
| FY2018 | -$2.5M | +31.9% |
| FY2017 | -$3.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CSBR financial trends
CSBR RevenueCSBR Net incomeCSBR Net marginCSBR Gross profitCSBR Gross marginCSBR Operating incomeCSBR Operating marginCSBR Operating cash flowCSBR Capital expendituresCSBR Return on equityCSBR Stock buybacksCSBR Dividends paidCSBR Total assetsCSBR Total liabilitiesCSBR Shareholders’ equityCSBR overview →